HALO logo
halo search icon
Artivion, Inc.

US$22.67

Price Change Indicator
-0.06 (-0.264%)
Artivion, Inc.
AORT · NYS

Artivion, Inc.

Start Trading AORT for Free

US$22.67

Price Arrow-0.06 (-0.264%)
20/05/2026 04:10:00 PM
All-CompaniesAll-ConsensusConsensus CheapHALO AllHALO Consensus ValueHammer BullishHammer Bullish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Artivion, Inc. Overview

AORT Health Scores

Short Term

Mean Reversion

Very Strong

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Weak

Balance Sheet

Very Weak

About AORT

icon
icon

Telephone

1.770.419.3355

icon

Address

1655 Roberts Boulevard NW, Kennesaw, GA 30144-3632

Description

Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes aortic stents and stent grafts, surgical sealants, and On-X products. The Preservation Services segment offers cardiac and vascular tissue preservation services. The company was founded on January 19, 1984, and is headquartered in Kennesaw, GA.

AORT Price Chart

Key Stats

Market Cap

US$1.10B

PE

220.40

EV/EBITDA

40.7

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 19.16 - 48.25

Trade Value (12mth)

US$4,098,662.00

1 week

-0.18%

1 month

-37.83%

YTD

-48.88%

1 year

-20.39%

All time high

48.25

Key Fundamentals

EPS 3 yr Growth

-145.10%

EBITDA Margin

12.80%

Operating Cashflow

$40m

Free Cash Flow Return

6.00%

ROIC

1.50%

Interest Coverage

2.10

Quick Ratio

2.10

Other Data

Shares Outstanding (Fully Diluted)

50m

HALO Sector

Healthcare

Next Company Report Date

18-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

AORT Announcements

Latest Announcements

DateAnnouncements
18 May 26
16 May 26
16 May 26
09 May 26
09 May 26

AORT Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-0.75-0.320.22locklocklock
EPS (Fully Diluted)
 $locklocklocklock-0.75-0.320.21locklocklock
Growth
 %locklocklocklock-57.357.3167.2locklocklock
PE
 XlocklocklocklockN/AN/A220.4locklocklock
EV/EBITDA
 Xlocklocklocklock25.928.240.7locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Artivion, Inc. (AORT:NYS)?
Halo FAQ
The current share price of Artivion, Inc. (AORT:NYS) is USD$22.67.
What is the 52-week high share price for Artivion, Inc. (AORT:NYS)?
Halo FAQ
The 52-week high share price for Artivion, Inc. (AORT:NYS) is USD$48.25.
What is the 52-week low share price for Artivion, Inc. (AORT:NYS)?
Halo FAQ
The 52-week low share price for Artivion, Inc. (AORT:NYS) is USD$19.16.
What is the dividend yield for Artivion, Inc. (AORT:NYS)?
Halo FAQ
Artivion, Inc. (AORT:NYS) does not pay a dividend.
What was Artivion, Inc. (AORT:NYS) last dividend payment?
Halo FAQ
The last dividend payment of Artivion, Inc. (AORT:NYS) is USD$0.03.
What is the franking level for Artivion, Inc. (AORT:NYS)?
Halo FAQ
Artivion, Inc. (AORT:NYS) has a franking level of 0.00%.
In which sector is Artivion, Inc. (AORT:NYS) classified?
Halo FAQ
Artivion, Inc. (AORT:NYS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Artivion, Inc. (AORT:NYS)?
Halo FAQ
The current P/E ratio for Artivion, Inc. (AORT:NYS) is 220.40.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial